Trends in rates of herpes zoster-related hospitalizations: Are they real, are they costly, and are they linked to varicella vaccination?

Infection Control and Hospital Epidemiology

Volumn 30, Issue 5, 2009, Pages 495-496

  Harpaz, Rafael ^a   Yawn, Barbara P ^b  

^a NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

^b OLMSTED MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VARICELLA ZOSTER VACCINE; CHICKENPOX VACCINE;

COST EFFECTIVENESS ANALYSIS; HERPES ZOSTER; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LETTER; POSTHERPETIC NEURALGIA; VACCINATION; VARICELLA ZOSTER VIRUS; CHICKENPOX; ECONOMICS; INCIDENCE; NOTE; STATISTICS; UNITED STATES;

CHICKENPOX; CHICKENPOX VACCINE; HERPES ZOSTER; HOSPITALIZATION; HUMANS; INCIDENCE; UNITED STATES; VACCINATION;

EID: 67649723830     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/597233     Document Type: Letter

References (11)

1. Patel MS, Gebremariam A, Davis MM. Herpes zoster-related hospitalizations and expenditures before and after introduction of the varicella vaccine in the United States. Infect Control Hosp Epidemiol 2008; 29: 1157-1163.
2. Jackson LA, Reynolds MA, Harpaz R. Hospitalizations to treat herpes zoster in older adults: causes and validated rates. Clin Infect Dis 2008; 47: 754-759.
3. Yawn BP, Saddier S, Wollan P, Sauver JS, Kurland M, Sy L. A populationbased study of the incidence and complications of herpes zoster before zoster vaccine introduction. Mayo Clin Proc 2007; 82:1341-1349.
4. Lin F, Hadler JL. Epidemiology of primary varicella and herpes zoster hospitalizations: the prevaricella vaccine era. J Infect Dis 2000; 181:1897-1905.
5. Brisson M, Gay NJ, Edmunds WJ, Andrews NJ. Exposure to varicella boosts immunity to herpes zoster: implications for mass vaccination against chickenpox. Vaccine 2002; 20:2500-2507.
6. Jumaan A, Yu O, Jackson L, Bohlke K, Galil K, Seward J. Incidence of herpes zoster, before and after varicella vaccination-associated decreases in the incidence of varicella, 1992-2002. J Infect Dis 2005; 191:2002-2007.
7. Mullooly JP, Riedlinger K, Chun C, Weinmann S, Houston H. Incidence of herpes zoster, 1997-2002. Epidemiol Infect 2005; 133:245-253.
8. Yih WK, Brooks DR, Lett SM, et al. The incidence of varicella and herpes zoster in Massachusetts as measured by the Behavioral Risk Factor Surveillance System (BRFSS) during a period of increasing varicella vaccine coverage, 1998-2003. BMC Public Health 2005; 5:68.
9. Ragozzino MW, Melton LJ 3rd, Kurland LT, Chu CP, Perry HO. Population- based study of herpes zoster and its sequelae. Medicine 1982; 61: 310-316.
10. Perez-Farinos N, Ordobas M, Garcia-Fernandez C, et al. Varicella and herpes zoster in Madrid, based on the Sentinel General Practitioner Network: 1997-2004. BMC Infect Dis 2007; 7:59.
11. Russell ML, Schopflocher DP, Svenson L, Virani SN. Secular trends in the epidemiology of shingles in Alberta. Epidemiol Infect 2007; 135:908-913.